AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2019
Mar 20, 2019
31676_dirs_2019-03-20_d9934d9b-fcdf-4006-a8b1-db6bcf2c7b0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-03-18
Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-18 | Common Stock | S | 24802 | $63.53 | Disposed | 205076 | Direct |
| 2019-03-19 | Common Stock | S | 2823 | $63.51 | Disposed | 205076 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-18 | Stock Options | $33.00 | M | 6375 | Disposed | 2024-03-31 | Common Stock (6375) | Direct |
| 2019-03-18 | Stock Options | $40.59 | M | 9375 | Disposed | 2026-04-06 | Common Stock (9375) | Direct |
| 2019-03-18 | Stock Options | $49.51 | M | 9052 | Disposed | 2027-03-30 | Common Stock (9052) | Direct |
| 2019-03-19 | Stock Options | $49.51 | M | 2823 | Disposed | 2027-03-30 | Common Stock (2823) | Direct |
Footnotes
F1: The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
F2: The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
F3: Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014.
F4: Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016.
F5: Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017.